Boudewijn van Vliet
Director/Board Member bij PRYME N.V.
Actieve functies van Boudewijn van Vliet
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PRYME N.V. | Director/Board Member | 11-02-2021 | - |
Director of Finance/CFO | - | - | |
Antion Biosciences SA
Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Director/Board Member | 09-08-2023 | - |
Chairman | - | 09-08-2023 |
Loopbaan van Boudewijn van Vliet
Statistieken
Internationaal
Zwitserland | 2 |
Nederland | 2 |
Operationeel
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Chairman | 1 |
Sectoraal
Health Technology | 2 |
Industrial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PRYME N.V. | Industrial Services |
Bedrijven in privébezit | 1 |
---|---|
Antion Biosciences SA
Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Health Technology |
- Beurs
- Insiders
- Boudewijn van Vliet
- Ervaring